HomeClinical TopicsFDA approves product for treating diabetic foot ulcers

FDA approves product for treating diabetic foot ulcers

On January 7, the Food and Drug Administration (FDA) approved a new indication for the Integra Omnigraft Dermal Regeneration Matrix (Omnigraft) to treat certain diabetic foot ulcers. Read more.

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Most Recent Content